Efficacy of phenytoin, valproic acid, carbamazepine and new antiepileptic drugs on control of late-onset post-stroke epilepsy in Taiwan

European Journal of Neurology

Volumn 22, Issue 11, 2015, Pages 1459-1468

  Huang, Y H ^a,b   Chi, N F ^a,b   Kuan, Y C ^a,b,c   Chan, L ^a,b   Hu, C J ^a,b   Chiou, H Y ^d   Chien, L N ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiepileptic drugs; Cerebrovascular disease stroke; Epilepsy seizures; Treatment

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEMENTIA; DRUG EFFICACY; EMERGENCY WARD; EPILEPSY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; POST STROKE EPILEPSY; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STROKE PATIENT; TAIWANESE; TRAUMATIC BRAIN INJURY; CEREBROVASCULAR ACCIDENT; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; PUBLIC HEALTH; SEIZURES; STATISTICS AND NUMERICAL DATA; TAIWAN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMAZEPINE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); PHENYTOIN; SEIZURES; STROKE; TAIWAN; VALPROIC ACID;

EID: 84943348040     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12766     Document Type: Article

References (52)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34: 453-468.
2. Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke. Lancet Neurol 2011; 10: 357-371.
3. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997; 315: 1582-1587.
4. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57: 1617-1622.
5. Lamy C. [Epilepsy and stroke]. Rev Neurol (Paris) 2008; 164: 841-845.
6. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001; 57: 200-206.
7. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 1996; 46: 350-355.
8. Gupta SR, Naheedy MH, Elias D, Rubino FA. Postinfarction seizures. A clinical study. Stroke 1988; 19: 1477-1481.
9. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004; 35: 1769-1775.
10. De Reuck J. Management of stroke-related seizures. Acta Neurol Belg 2009; 109: 271-276.
11. Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav 2005; 7(Suppl 1): S1-S64; quiz S65-67.
12. Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013; 54: 551-563.
13. Huber DP, Griener R, Trinka E. Antiepileptic drug use in Austrian nursing home residents. Seizure 2013; 22: 24-27.
14. Galimberti CA, Magri F, Magnani B, et al. Antiepileptic drug use and epileptic seizures in elderly nursing home residents: a survey in the province of Pavia, Northern Italy. Epilepsy Res 2006; 68: 1-8.
15. Garrard J, Harms S, Hardie N, et al. Antiepileptic drug use in nursing home admissions. Ann Neurol 2003; 54: 75-85.
16. Huying F, Klimpe S, Werhahn KJ. Antiepileptic drug use in nursing home residents: a cross-sectional, regional study. Seizure 2006; 15: 194-197.
17. Rytter E, Nakken KO, Morch-Reiersen LT, Efjestad A, Selvig K. Use of antiepileptic drugs in nursing home residents. Tidsskr Nor Laegeforen 2007; 127: 1185-1187.
18. Johnell K, Fastbom J. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1, 300, 000 older people. Eur J Clin Pharmacol 2011; 67: 1069-1075.
19. Timmons S, McCarthy F, Duggan J, Twomey C. Anticonvulsant use in elderly patients in long-term care units. Ir J Med Sci 2003; 172: 66-68.
20. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37: 81-87.
21. Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, Lampl Y. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clin Neuropharmacol 2007; 30: 189-195.
22. Kutlu G, Gomceli YB, Unal Y, Inan LE. Levetiracetam monotherapy for late poststroke seizures in the elderly. Epilepsy Behav 2008; 13: 542-544.
23. Pugh MJ, Van Cott AC, Cramer JA, et al. Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004. Neurology 2008; 70: 2171-2178.
24. Hollingworth SA, Eadie MJ. Antiepileptic drugs in Australia: 2002-2007. Pharmacoepidemiol Drug Saf 2010; 19: 82-89.
25. Hsieh LP, Huang CY. Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study. Epilepsy Res 2011; 96: 81-88.
26. Procaccianti G, Zaniboni A, Rondelli F, Crisci M, Sacquegna T. Seizures in acute stroke: incidence, risk factors and prognosis. Neuroepidemiology 2012; 39: 45-50.
27. Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag 2008; 4: 715-720.
28. Lamy C, Domigo V, Semah F, et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003; 60: 400-404.
29. Silverman IE, Restrepo L, Mathews GC. Poststroke seizures. Arch Neurol 2002; 59: 195-201.
30. Menon B, Shorvon SD. Ischaemic stroke in adults and epilepsy. Epilepsy Res 2009; 87: 1-11.
31. Hsieh LP, Huang CY. Prevalence of treated epilepsy in western medicine among the adult population in Taiwan: a study conducted using antiepileptic drug prescription data. Epilepsy Res 2008; 80: 114-118.
32. Gaitatzis A, Carroll K, Majeed A, Sander JW. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004; 45: 1613-1622.
33. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62: S24-S29.
34. Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 2006; 13: 277-282.
35. European Stroke Organisation Executive C, Committee ESOW. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
36. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
37. Gilad R. Management of seizures following a stroke: what are the options? Drugs Aging 2012; 29: 533-538.
38. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64: 1868-1873.
39. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000-1015.
40. Kwan P, Brodie MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003; 60: S2-S12.
41. Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology 2006; 67: S3-S9.
42. Tsiropoulos I, Gichangi A, Andersen M, Bjerrum L, Gaist D, Hallas J. Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand 2006; 113: 405-411.
43. Savica R, Beghi E, Mazzaglia G, et al. Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. Eur J Neurol 2007; 14: 1317-1321.
44. Landmark CJ, Fossmark H, Larsson PG, Rytter E, Johannessen SI. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res 2011; 95: 51-59.
45. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. Arch Fam Med 1994; 3: 589-598.
46. Bernus I, Dickinson RG, Hooper WD, Eadie MJ. Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations. Drugs Aging 1997; 10: 278-289.
47. Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol 2009; 8: 1019-1030.
48. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163-184.
49. Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005; 331: 1317-1322.
50. Alvarez-Sabin J, Montaner J, Padro L, et al. Gabapentin in late-onset poststroke seizures. Neurology 2002; 59: 1991-1993.
51. Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B 1502 screening in Taiwan. N Engl J Med 2011; 364: 1126-1133.
52. Chien IC, Bih SH, Chou YJ, Lin CH, Lee WG, Chou P. Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997-2004. Psychiatr Serv 2007; 58: 554-557.